down arrow

LongBio Pharma (Suzhou) Co., Ltd.

  • Market Cap: N/A
  • Industry: Biotechnology
  • ISIN: CNE100007NF2
HKD
113.50
-3.9 (-3.32%)

Sep 25

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
LongBio Pharma (Suzhou) Co., Ltd.

Why is LongBio Pharma (Suzhou) Co., Ltd. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found
Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-6.61
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
70.32
EV to EBIT
-61.69
EV to EBITDA
-64.65
EV to Capital Employed
-720.54
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-122.44%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
Mildly Bearish
OBV
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
NET PROFIT(HY)

Higher at HKD -153.68 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-6What is not working for the Company
OPERATING PROFIT(Q)

Lowest at HKD -146.83 MM

PRE-TAX PROFIT(Q)

Lowest at HKD -153.68 MM

NET PROFIT(Q)

Lowest at HKD -153.68 MM

EPS(Q)

Lowest at HKD -2.07

Here's what is working for LongBio Pharma (Suzhou) Co., Ltd.

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at HKD 4.83 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation
At HKD 4.83 MM has Grown at 19.75%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for LongBio Pharma (Suzhou) Co., Ltd.

Operating Profit
Lowest at HKD -146.83 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (HKD MM)

Pre-Tax Profit
Lowest at HKD -153.68 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Pre-Tax Profit
Fallen at -51.14%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit
Lowest at HKD -153.68 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)

EPS
Lowest at HKD -2.07
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Footer loading